Evaluation of the effectiveness of Eliquis® (apixaban) risk minimization tools in European

First published 29/07/2015

Last updated 30/03/2024

EU PAS number:

EUPAS10443

Study

Finalised

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Evaluation of the effectiveness of Eliquis® (apixaban) risk minimization tools in European

Secondary tabs

Share this page